Related Experiment Video
Updated: Jun 16, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Hydroxyurea reduces infections in children with sickle cell anemia in Uganda
Ruth Namazzi1,2, Caitlin Bond3, Andrea L Conroy3
1Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda.
Insights
Hydroxyurea treatment significantly reduced severe infections in Ugandan children with sickle cell anemia by 60%. This included fewer cases of malaria, bacteremia, and respiratory or gastrointestinal infections.
Area of Science:
- Pediatrics
- Hematology
- Infectious Diseases
Background:
- Sickle cell anemia (SCA) is a genetic blood disorder prevalent in many parts of Africa.
- Children with SCA face a high risk of severe infections, leading to significant morbidity and mortality.
- Infections like malaria and bacteremia are particularly dangerous for SCA patients.
Purpose of the Study:
- To evaluate the impact of hydroxyurea treatment on the incidence of severe and invasive infections in Ugandan children with sickle cell anemia.
Main Methods:
- A retrospective analysis of infection rates in Ugandan children with SCA before and after initiating hydroxyurea therapy.
- Infection types analyzed included malaria, bacteremia, respiratory tract infections, and gastroenteritis.
Main Results:
- Hydroxyurea treatment was associated with a 60% reduction in severe or invasive infections.
- The incidence rate ratio for infections after starting hydroxyurea was 0.40 (95% CI, 0.29-0.54), indicating a significant protective effect (P < .001).
Conclusions:
- Hydroxyurea therapy is effective in decreasing the burden of severe infections in children with sickle cell anemia in Uganda.
- This finding supports the use of hydroxyurea as a crucial intervention to improve outcomes for SCA patients in high-burden regions.
Abstract:
After starting hydroxyurea treatment, Ugandan children with sickle cell anemia had 60% fewer severe or invasive infections, including malaria, bacteremia, respiratory tract infections, and gastroenteritis, than before starting hydroxyurea treatment (incidence rate ratio, 0.40 [95% confidence interval, 0.29-0.54]; P < .001).
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

